EVALUATION OF DRUG-RELATED PROBLEMS IN POLYMEDICATED PATIENTS

Authors

  • Aline Aparecida Pereira Souza Centro Universitário Integrado de Campo Mourão - PR. Rodovia BR 158, Km 207, CEP: 87300-970, Campo Mourão –PR, Brasil, Tel/Fax: +55 (44) 3518 2500. http://orcid.org/0000-0001-7344-9675
  • Ana Carla Broetto-Biazon Centro Universitário Integrado de Campo Mourão - PR. Rodovia BR 158, Km 207, CEP: 87300-970, Campo Mourão –PR, Brasil, Tel/Fax: +55 (44) 3518 2500. http://orcid.org/0000-0001-7235-990X
  • Tânia Pereira Salci-Aran Centro Universitário Integrado de Campo Mourão - PR. Rodovia BR 158, Km 207, CEP: 87300-970, Campo Mourão –PR, Brasil, Tel/Fax: +55 (44) 3518 2500. http://orcid.org/0000-0002-7688-1225

DOI:

https://doi.org/10.14450/2318-9312.v33.e1.a2021.pp67-74

Keywords:

pharmaceutical assistance, polymedication, health worker-patient relations, pharmacological treatment.

Abstract

Although the objective is to improve the quality of life, polymedication is directly associated with the increased likelihood that the patient will develop  drug-related problems (DRP), thus compromising the treatment’s  effectiveness, besides generating risks for the treatment and health. Thus,  the present study performed pharmacotherapeutic follow-up in  polymedicated patients from a community pharmacy service. The present  study aimed to carry out pharmacotherapeutic follow-up in polymedicated  patients using a community pharmacy service through a prospective and  quantitative study in a pharmacy school at Campo Mourão, PR, Brazil.  Twenty-six patients with chronic diseases and being treated with five or  more medications were included in the study. The pharmacotherapeutic  follow-up was performed based on the methodology proposed by the Dáder  method. Drugdex®, Dynamed, and ANVISA’s electronic files were used to  evaluate the therapy. DRP were classified according to Rovers and Currie,  and the Beers criteria were used to identify inappropriate drugs for the  elderly. Most patients were elderly (80.8%), with three or more diseases and on average use of eight medications. 108 DRP (mean: 4.9 DRP/patient) were observed, which resulted in 76 proposals for pharmaceutical interventions to patients. Among the identified DRP, those related to safety (40.7%),  effectiveness (35.2%), and adverse reactions (27.8%) were highlighted. Among the factors that can be pointed out as predisposing to  the high incidence of PRM, polymedication, advanced age and the presence of chronic diseases stand out.

Downloads

Published

2021-03-30

How to Cite

Pereira Souza, A. A., Broetto-Biazon, A. C., & Salci-Aran, T. P. (2021). EVALUATION OF DRUG-RELATED PROBLEMS IN POLYMEDICATED PATIENTS. Infarma - Pharmaceutical Sciences, 33(1), 67–74. https://doi.org/10.14450/2318-9312.v33.e1.a2021.pp67-74

Issue

Vol. 33 No. 1 (2021)

Section

Original article

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).